Read about the latest company developments, innovations, partnerships and more.
Alimentiv’s model attracts eyes across the medical community and beyond. Here are the latest stories people are telling about us, our mission and our unique Health Trust.
Read More
On International Women’s Day 2023, in keeping with this year’s theme of “Embrace Equity”, Alimentiv continues to celebrate the achievements of women, their courage and determination to take action for equality and raise awareness against bias. We believe in empowering women, so in honour of IWD 2023, we are proud to profile a few of […]… read more
London, Ontario, Canada, November 3, 2022, Alimentiv Inc. (“Alimentiv”) and Summit Clinical Research, LLC (“Summit”) today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis (NASH) drug development programs forward faster and more efficiently. NASH is a growing global epidemic with no approved treatments. There are over 100 drugs in clinical development (Fraile et al., 2021). […]… read more
The partnership enables advanced AI-fueled HD video capture, decision support, and clinical research tools for Alimentiv’s global clinical trial investigator site network. London, Ontario, Canada, 5 October 2022 – Alimentiv Inc. (“Alimentiv”), Satisfai Health, Inc (“Satisfai”), and Virgo Surgical Video Solutions, Inc. (“Virgo”) today announced a strategic partnership to revolutionize central reading, data capture, decision […]… read more
San Diego, CA, USA, Release: September 15, 2022 – AcelaBio (US) Inc., a contract research organization delivering histopathology and precision medicine laboratory services for global clinical trials, achieved its accreditation by the College of American Pathologists (CAP). CAP accreditation indicates that the laboratory meets stringent requirements of quality, accuracy, and consistency of test results to […]… read more
London, ON, CANADA, Release: August 18, 2022 Alimentiv Health Trust is pleased to announce the appointment of Dr. Amara Siva, Mr. John Fox and Mr. Paul Rothwell to the Alimentiv Holdings Board of Directors. “We are pleased to welcome Amara, John and Paul to the Alimentiv Holdings Board”, said Jeff Smith, CEO Alimentiv Inc. and Director […]… read more
At Alimentiv, our employees come first. We engage inspired and talented individuals who are motivated by our mission and vision, and we continue to learn more about our employees and their unique and niche backgrounds that make up the diverse workforce behind our clinical trial services. Today, we are highlighting one of our employees, Jill Klein, Senior Database Programmer in Data Sciences. We asked Jill some questions and to take us through a day in her role!… read more
London, ON, CANADA, Release: January 27, 2022 The International Bowel Ultrasound (IBUS) Group e.V. and Alimentiv Inc. announced today a partnership to offer intestinal ultrasound (IUS) central reading services in clinical trials of adults and children with inflammatory bowel disease (IBD). Owing to its cost-effectiveness, tolerability and repeatability, IUS has played an increasing role as… read more
Join our expert panel where they will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including Histopathology as a treatment target in IBD: Aspiration or Reality? Measuring histopathology in IBD trials Histopathology as a treatment target… read more
Alimentiv is proud to continuously honour and recognize the achievements of women and foster this culture globally amongst our employees and prospective candidates. This month, we are taking time to highlight Judi Hall, Vice President, Clinical Research for Alimentiv. Judi took some time to discuss her growth and development within the company, motivation, and inspiration… read more
London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering sponsors real-time data and secure access to all clinical documentation throughout the clinical trial lifecycle. As part of its strategy to modernize its technology landscape, Alimentiv selected Vault eTMF to improve… read more
Alimentiv is proud to continuously honour and recognize the achievements of women and foster this culture globally amongst our employees and prospective candidates. This month, we are taking time to highlight Arti Ramji, Senior Manager, Human Resources & Engagement for Alimentiv. Arti took some time to discuss her growth and development within the company, motivation,… read more
Alimentiv is pleased to announce that Mike Reffeitt joined Alimentiv Inc. as the new Chief Financial Officer, effective Monday, May 3, 2021. Mike will be working alongside the executive team to drive the business and strategy of the Alimentiv group of companies forward and support our corporate operations teams including IT, legal, quality, facilities, and… read more
London, ON, CANADA, Release: April 14, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), and McDougall Scientific Ltd., a niche CRO, announced today the launch of AcelaBio, a commercial state-of-the-art research laboratory delivering histopathology and precision medicine services for… read more
International Women’s Day 2021 is on Monday, March 8th. Alimentiv is proud to celebrate this, honour the achievements of women across the globe, and continues to foster a culture where all employees and prospective candidates receive equal opportunities…. read more
London, ON, CANADA, Release: March 2, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), announced today the acquisition of McDougall Scientific Ltd. a niche CRO specializing in statistical analysis, top-tier data management, reporting, and clinical trial design. The acquisition… read more
A patient reported outcome measure, or PRO, may be defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else.” These measures are widely used to study chronic diseases and are considered by regulatory agencies such… read more
Our corporate team “IBD Eliminators” are featured as the Corporate Team for Gutsy Walk! Including dedicated employees of Alimentiv Clinical Trials and supportive friends and family, our team has participated since 2017…. read more
ST. PAUL, Minn., June 25, 2020 (GLOBE NEWSWIRE) — Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC)…. read more
Alimentiv, Inc. formerly Robarts Clinical Trials, announced today a major rebranding to reflect the company’s continued growth as a specialized global gastrointestinal (GI) contract research organization (CRO)…. read more
Alimentiv’s Response to the COVID-19 pandemic and how we are still working to provide safe, quality service to our partners, sponsors, vendors and investigators…. read more